$24.30
-0.56[-2.25%]
At close: May 10
$24.30
0[0.00%]
After Hours: 5:54PM EDT
Intellia Therapeutics
(NASDAQ:NTLA)Intellia Therapeutics Stock (NASDAQ:NTLA), Earnings Estimates, EPS, and Revenue
Intellia Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 9
EPS
$-1.120
Quarterly Revenue
$28.9M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$52.6M
Analyze the earnings history of Intellia Therapeutics using advanced sorting and filters.
No data available to display
ticker | Company Name | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Date | Get Alert |
|---|
FAQ
When is Intellia Therapeutics (NASDAQ:NTLA) reporting earnings?
Intellia Therapeutics (NTLA) is scheduled to report earnings on August 1, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for Intellia Therapeutics (NASDAQ:NTLA)?
The Actual EPS was $-1.12, which beat the estimate of $-1.38.
What were Intellia Therapeutics’s (NASDAQ:NTLA) revenues?
The Actual Revenue was $28.9M, which beat the estimate of $11.5M.
Browse earnings estimates, EPS, and revenue on all stocks.